Molecule to Market: Inside the outsourcing space
Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines (just think of your favourite podcast and that’s what we’re doing, but with drug supply chain shortages instead of unsolved crimes and life science leaders instead of sports stars). Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.
- Update frequency
- every 6 days
- Average duration
- 45 minutes
- Episodes
- 235
- Years Active
- 2020 - 2025
Mission-driven doctor, inventor & entrepreneur
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Doctor Eric Edwards, Co-Founder and CEO at Phlow.
Your host, Raman Sehgal, …
The boomerang boy impacting gene therapies
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Andy Holt, CCO of Viralgen Vector Core.
Your host, Raman Sehgal, discusses the…
Taking on the biologics CDMOs from down under
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mark W. Womack, Chief Executive Officer at BioCina.
Your host, Raman Sehgal, d…
A true nerd of CGT
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Bill Vincent, Founder and board chair at Genezen.
Your host, Raman Sehgal, dis…
The virtual and decentralized clinical trials specialists
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Helen Shaw and Dan Henley, co-founders of VCTC.
Your host, Raman Sehgal, discu…
Jumping into CDMO after a lifetime as a sponsor
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Bill Humphries, CEO at Alcami.
Your host, Raman Sehgal, discusses the pharmace…
Zero to a billion... A CDMO original - part 2
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector for part 2 of our conversation with Thomas Eldered, Executive Chairman at Flerie.
Y…
Zero to a billion... A CDMO original - part 1
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with part 1 of our episode with Thomas Eldered, Executive Chairman at Flerie.
Yo…
Dan’s the man...at Custom Biologics
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dan Mamelak, Founder & President at Custom Biologics.
Your host, Raman Sehgal,…
Celebrating female talent in life sciences
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with:
The power of peptides
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Alastair Hay, Vice President of Peptides at Almac Sciences.
Your host, Raman S…
From Pfizer to CDMO carve-out
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Brett Alderson, President and Site Leader of Novacina.
Your host, Raman Sehgal…
One-hour special: Meet the next big thing in obesity
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Arvid Söderhall, CEO at Empros Pharma.
Your host, Raman Sehgal, discusses t…
M&A Roundtable and 2024 Predictions
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with:
- Sabina Ouimet-Storrs, Principal at GHO Capital Partners
- James West, Managing …
Transforming a family pharma firm
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Elisabeth Stampa, President Medicines for Europe and Board Chair at Medichem.
…
From MassBio... to the world
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kendalle Burlin O’Connell, CEO and President of MassBio.
Your host, Raman Se…
From banking to biotech
Founder of the Center for Breakthrough Medicines - now part of SK Pharmteco.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Audrey, covering:
- How a ca…
Dealing with downturns... and the menopause.
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Denise Bowser, Co-Founder and Commercial Director of Onyx Scientific.
Your hos…
The dealmaker now redefining commercialization
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dominic (Nick) Marasco, Executive President and Chief Commercial Officer at En…
The biotech CDMO planning to impact the US
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Himanshu Gadgil, CEO at Enzene Biosciences.
Your host, Raman Sehgal, discus…